Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Capital Leases (2016 - 2023)

Historic Capital Leases for AtriCure (ATRC) over the last 10 years, with Q4 2023 value amounting to $8.1 million.

  • AtriCure's Capital Leases fell 1187.27% to $8.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $8.1 million, marking a year-over-year decrease of 1187.27%. This contributed to the annual value of $8.1 million for FY2023, which is 1187.27% down from last year.
  • Per AtriCure's latest filing, its Capital Leases stood at $8.1 million for Q4 2023, which was down 1187.27% from $8.3 million recorded in Q3 2023.
  • Over the past 5 years, AtriCure's Capital Leases peaked at $12.0 million during Q1 2019, and registered a low of $8.1 million during Q4 2023.
  • Over the past 5 years, AtriCure's median Capital Leases value was $10.4 million (recorded in 2021), while the average stood at $10.3 million.
  • Its Capital Leases has fluctuated over the past 5 years, first tumbled by 326.98% in 2019, then tumbled by 1187.27% in 2023.
  • Over the past 5 years, AtriCure's Capital Leases (Quarter) stood at $11.8 million in 2019, then dropped by 6.84% to $11.0 million in 2020, then dropped by 8.09% to $10.1 million in 2021, then decreased by 9.27% to $9.1 million in 2022, then dropped by 11.87% to $8.1 million in 2023.
  • Its Capital Leases stands at $8.1 million for Q4 2023, versus $8.3 million for Q3 2023 and $8.6 million for Q2 2023.